Frailty Syndrome in Daily Practice of Interventional Cardiology Ward
Launched by MEDICAL UNIVERSITY OF SILESIA · Jul 3, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The FRAPICA study is investigating how frailty affects the treatment and outcomes for older adults with heart conditions, specifically those with coronary artery disease. Frailty refers to a state of increased vulnerability, often seen in older adults, which can impact their ability to recover from medical procedures. This study aims to help doctors understand the best ways to treat these patients by using specific assessment tools that measure frailty and daily living skills. By doing so, researchers hope to improve patient care and tailor treatments based on individual needs.
To participate in this study, individuals must be 65 years or older and have symptomatic coronary artery disease, which can include stable or unstable conditions and types of heart attacks. Participants will undergo assessments before leaving the hospital, and their health outcomes will be monitored over the next three years. This includes looking at treatment success, any complications, and overall health status. By joining the FRAPICA study, participants contribute to important research that could lead to better care for older adults facing heart issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • aged ≥ 65
- • symptomatic coronary artery disease A) stable B) unstable C) NSTEMI D) STEMI
- • written, informed consent
- Exclusion Criteria:
- • lack of consent
About Medical University Of Silesia
The Medical University of Silesia is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. Located in Poland, the university is renowned for its commitment to medical education, interdisciplinary collaboration, and the development of new therapeutic approaches. With a focus on translating scientific discoveries into practical applications, the Medical University of Silesia sponsors a range of clinical trials aimed at improving patient outcomes and enhancing the understanding of various medical conditions. Through its rigorous ethical standards and robust research infrastructure, the university plays a pivotal role in shaping the future of medicine both regionally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zabrze, Upper Silesia, Poland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials